Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 13;6(1):25.
doi: 10.3390/microorganisms6010025.

Antibody-Based Agents in the Management of Antibiotic-Resistant Staphylococcus aureus Diseases

Pietro Speziale  1   2 , Simonetta Rindi  3 , Giampiero Pietrocola  4
Affiliations
Review

Antibody-Based Agents in the Management of Antibiotic-Resistant Staphylococcus aureus Diseases

Pietro Speziale et al. Microorganisms. .

Abstract

Staphylococcus aureus is a human pathogen that can cause a wide spectrum of diseases, including sepsis, pneumonia, arthritis, and endocarditis. Ineffective treatment of a number of staphylococcal infections with antibiotics is due to the development and spread of antibiotic-resistant strains following decades of antibiotic usage. This has generated renewed interest within the scientific community in alternative therapeutic agents, such as anti-S. aureus antibodies. Although the role of antibodies in the management of S. aureus diseases is controversial, the success of this pathogen in neutralizing humoral immunity clearly indicates that antibodies offer the host extensive protection. In this review, we report an update on efforts to develop antibody-based agents, particularly monoclonal antibodies, and their therapeutic potential in the passive immunization approach to the treatment and prevention of S. aureus infections.

Keywords: Staphylococcus aureus; antibodies; passive immunization; virulence factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998;339:520–532. doi: 10.1056/NEJM199808203390806. - DOI - PubMed
    1. Speziale P., Visai L., Rindi S., Pietrocola G., Provenza G., Provenzano M. Prevention and treatment of Staphylococcus biofilms. Curr. Med. Chem. 2008;15:3185–3195. doi: 10.2174/092986708786848442. - DOI - PubMed
    1. Foster T.J., Geoghegan J.A., Ganesh V.K., Höök M. Adhesion, invasion and evasion: The many functions of the surface proteins of Staphylococcus aureus. Nat. Rev. Microbiol. 2014;12:49–62. doi: 10.1038/nrmicro3161. - DOI - PMC - PubMed
    1. Krismer B., Weidenmaier C., Zipperer A., Peschel A. The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat. Rev. Microbiol. 2017;15:675–687. doi: 10.1038/nrmicro.2017.104. - DOI - PubMed
    1. Williamson D.A., Ritchie S., Keren B., Harrington M., Thomas M.G., Upton A., Lennon D., Leversha A. Persistence, Discordance and Diversity of Staphylococcus aureus Nasal and Oropharyngeal Colonization in School-aged Children. Pediatr. Infect. Dis. J. 2016;35:744–748. doi: 10.1097/INF.0000000000001173. - DOI - PubMed

LinkOut - more resources